Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SEGG
13376
Sports Entertainment Gaming Global Corp
SEGG
$7.17M
| $14.2K | ﹤0.01% |
+419
| New | +$11.8K |
2024 Q4
0 quarters
|
|
13377
PUT
Trustmark
TRMK
$2.64B
| $14.1K | ﹤0.01% |
400
+300
| +300% | +$10.8K |
2024 Q3
1 quarter
|
|
13378
CALL
Gilat Satellite Networks
GILT
$724M
| $14.1K | ﹤0.01% |
2,300
+1,700
| +283% | +$9.26K |
2022 Q3
9 quarters
|
|
13379
PUT
BBB Foods
TBBB
$6.49B
| $14.1K | ﹤0.01% |
500
-800
| -62% | -$24.9K |
2024 Q1
3 quarters
|
|
|
INZY
13380
PUT
DELISTED
Inozyme Pharma
INZY
| $14.1K | ﹤0.01% |
5,100
-700
| -12% | -$2.66K |
2023 Q1
7 quarters
|
|
13381
CALL
Consumer Portfolio Services
CPSS
$197M
| $14.1K | ﹤0.01% |
+1,300
| New | +$13.3K |
2024 Q4
0 quarters
|
|
13382
PUT
Capital Group Dividend Value ETF
CGDV
$39B
| $14.1K | ﹤0.01% |
+400
| New | +$14.6K |
2024 Q4
0 quarters
|
|
|
KW
13383
CALL
DELISTED
Kennedy-Wilson Holdings
KW
| $14K | ﹤0.01% |
1,400
-17,100
| -92% | -$187K |
2022 Q3
9 quarters
|
|
13384
Urban One Class D
UONEK
$15.9M
| $14K | ﹤0.01% |
1,402
-731
| -34% | -$7.61K |
2024 Q3
1 quarter
|
|
13385
PUT
Pangaea Logistics
PANL
$558M
| $13.9K | ﹤0.01% |
2,600
-1,600
| -38% | -$9.64K |
2022 Q4
8 quarters
|
|
13386
PUT
South Plains Financial
SPFI
$805M
| $13.9K | ﹤0.01% |
400
+300
| +300% | +$10.9K |
2024 Q3
1 quarter
|
|
13387
PUT
Innoviva
INVA
$1.49B
| $13.9K | ﹤0.01% |
800
+500
| +167% | +$9.6K |
2022 Q4
8 quarters
|
|
|
MRSN
13388
PUT
DELISTED
Mersana Therapeutics
MRSN
| $13.9K | ﹤0.01% |
388
-700
| -64% | -$36.2K |
2023 Q1
7 quarters
|
|
13389
PUT
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.91B
| $13.9K | ﹤0.01% |
+600
| New | +$14.4K |
2024 Q4
0 quarters
|
|
13390
PUT
First Financial Corp
THFF
$888M
| $13.9K | ﹤0.01% |
300
-200
| -40% | -$9.27K |
2024 Q3
1 quarter
|
|
13391
CALL
PC Connection
CNXN
$2.33B
| $13.9K | ﹤0.01% |
200
-900
| -82% | -$64.7K |
2023 Q4
4 quarters
|
|
|
BRFS
13392
CALL
DELISTED
BRF SA
BRFS
| $13.8K | ﹤0.01% |
3,400
-173,700
| -98% | -$754K |
2022 Q3
9 quarters
|
|
13393
CALL
Enlivex Ltd
ENLV
$7.21M
| $13.8K | ﹤0.01% |
787
-600
| -43% | -$11.7K |
2022 Q2
10 quarters
|
|
13394
CALL
Organogenesis Holdings
ORGO
$166M
| $13.8K | ﹤0.01% |
+4,300
| New | +$14.4K |
2024 Q4
0 quarters
|
|
13395
VICI Properties
VICI
$24.8B
| $13.8K | ﹤0.01% |
471
-3,700,203
| -100% | -$117M |
2022 Q3
9 quarters
|
|
13396
CALL
NN Inc
NNBR
$350M
| $13.7K | ﹤0.01% |
4,200
+3,300
| +367% | +$12.6K |
2022 Q4
8 quarters
|
|
13397
PUT
Rezolute
RZLT
$419M
| $13.7K | ﹤0.01% |
2,800
-21,800
| -89% | -$110K |
2024 Q3
1 quarter
|
|
13398
PUT
Tango Therapeutics
TNGX
$3.89B
| $13.6K | ﹤0.01% |
4,400
+2,900
| +193% | +$13.5K |
2024 Q1
3 quarters
|
|
|
IRS
13399
PUT
IRSA Inversiones y Representaciones
IRS
$1.18B
| $13.6K | ﹤0.01% |
909
-1,370
| -60% | -$19.4K |
2023 Q1
7 quarters
|
|
13400
PUT
iShares Asia 50 ETF
AIA
$5.08B
| $13.6K | ﹤0.01% |
200
| – | – |
2024 Q1
3 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.